Halaman 2 - Timoma Dokter Terbaik - TOP-59 dokter

Dr. Yildiz berspesialisasi dalam timoma dan tumor neuroendokrin, dengan penelitian ekstensif yang dipublikasikan di jurnal medis internasional.

• Menerbitkan 17+ studi tentang kondisi onkologi langka
• Keahlian dalam mendiagnosis dan mengobati kasus timoma yang kompleks
• Bekerja di Rumah Sakit Universitas Medipol Mega – pusat onkologi terkemuka

Profesor Ondzhel berspesialisasi dalam bedah onkologi dengan fokus pada kanker kolorektal dan rektum, melakukan prosedur kompleks di Rumah Sakit Universitas Medipol Mega.

• Menjalani pelatihan di Cleveland Clinic – pemimpin dalam bedah kolorektal
• Proktologis bersertifikat Komisi Eropa dengan pengalaman lebih dari 25 tahun
• Riset yang dipublikasikan tentang adenokarsinoma rektum dan reseksi kanker multiviskeral
• Kepala Departemen Bedah di Universitas Medipol Istanbul
• Anggota pendiri Eurasian Colorectal Technologies Association

Dr. Alemdar berspesialisasi dalam pengobatan timoma dengan pengalaman luas di bidang onkologi medis di rumah sakit terkemuka di Turki.

• Menempuh pendidikan di Universitas Akdeniz – lembaga medis terkemuka di Turki
• Berpengalaman lebih dari 15 tahun di bidang onkologi dan penyakit dalam
• Bekerja di Medical Park Antalya Hospital Complex – dilengkapi dengan fasilitas perawatan kanker yang canggih
• Anggota Asosiasi Onkologi Medis Turki

Univ. Prof. Dr. Wolfgang Köstler adalah pakar terkemuka dalam terapi kanker bertarget, dengan pengalaman lebih dari dua dekade di bidang onkologi medis.

• Spesialisasi dalam kanker payudara dan keganasan ginekologi
• Wakil Kepala Divisi Klinis Onkologi di Universitas Kedokteran Wina
• Fokus pada terapi kanker sistemik individual dan imunoterapi
• Penelitian yang dipublikasikan tentang pengembangan biomarker dan biologi tumor

Prof. Walter Klepetko memelopori transplantasi paru-paru pertama di Austria dan membangun salah satu program bedah toraks terkemuka di Eropa di Universitas Kedokteran Wina.

• Lebih dari 40 tahun spesialisasi dalam onkologi toraks kompleks dan transplantasi paru-paru
• Mantan Kepala Bedah Toraks di Universitas Kedokteran Wina
• Mengembangkan teknik invasif minimal tingkat lanjut untuk tumor toraks
• Terkenal karena menangani kasus berisiko tinggi dan reseksi kompleks

Profesor Keil berspesialisasi dalam teknik pencitraan tingkat lanjut untuk diagnosis timoma yang tepat di Medical Center di Solingen.

• Lulus dengan pujian dari Julius-Maximilians-Universität Würzburg
• Ahli dalam diagnostik MRI, CT, dan ultrasonografi
• Kepala Dokter Radiologi Diagnostik dan Intervensional sejak 2022
• Menjalani pelatihan di bawah bimbingan ahli radiologi ternama di Jerman
• Menawarkan rangkaian lengkap layanan radiologi intervensional

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Lebih dari 30 tahun pengalaman dalam imunologi – Dr. Jaunalksne berspesialisasi dalam viroterapi, bidang mutakhir untuk pengobatan timoma.

• Memimpin Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulus dari Institut Medis Riga dengan magang di Kedokteran Internal
• Berfokus pada pendekatan imunologi yang inovatif

Prof. Madya Nail Paksoy membawa keahlian dari Institut Onkologi Universitas Istanbul dan Rumah Sakit Medipol Bahçelievler, dengan fokus pada timoma dan keganasan toraks lainnya.

• Tersertifikasi Dewan ESMO dalam Onkologi Medis sejak 2022
• Menulis penelitian tentang kanker toraks langka yang diterbitkan dalam jurnal internasional
• Berpartisipasi dalam 8 uji klinis internasional untuk terapi kanker terbaru
• Spesialisasi dalam imunoterapi dan pendekatan terapi target

Dr. Felix Dobritoiu menggunakan teknik invasif minimal mutakhir seperti bedah robotik (da Vinci Xi) dan uniportal VATS untuk pengobatan timoma di Ponderas Academic Hospital.

• Spesialisasi dalam bedah toraks dengan keahlian dalam reseksi mediastinum yang kompleks
• Menggunakan sayatan kecil untuk pemulihan lebih cepat dan mengurangi nyeri pasca-operasi
• Melakukan prosedur tanpa drainase pleura pasca-operasi jika memungkinkan
• Terlatih dalam teknik tingkat lanjut termasuk prosedur Nuss

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Amr Mahmoud Al Demery is a consultant thoracic surgical oncologist with 12 years of experience. He holds an M.B.B.Ch from Kasr El-Aini, Cairo University (2007). He earned a Master’s in Surgical Oncology in 2014 and a Doctorate in Surgical Oncology in 2019 from the National Cancer Institute, Cairo University. He is a Member of the Royal College of Surgeons of England (MRCS, 2014). He speaks English and Arabic.

His practice includes the assessment, diagnosis, and surgical treatment of thoracic cancers. He performs bronchoscopy, thoracoscopy, and mediastinoscopy. He carries out lung resections, including wedge resection, lobectomy, bilobectomy, and pneumonectomy. He also performs esophageal resection with reconstruction and pleural decortication. His work includes thymectomy and mediastinal lymph node dissection. He performs chest wall and diaphragmatic tumor resection with reconstruction.

He served as Resident, Assistant Lecturer, and Lecturer of Surgical Oncology at the National Cancer Institute, Cairo University. He is a consultant in thoracic surgical oncology at Dar El-Salam, Tanta, Damanhour, and Shefaa Al Orman Cancer Centers. He is a member of the Egyptian Society of Surgical Oncology. He is a cofounder and member of the Egyptian Society of Respiratory Neoplasms.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.